Foster & Motley’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.38M | Sell |
27,428
-3,463
| -11% | -$332K | 0.12% | 155 |
|
|
2025
Q4 | $2.97M | Sell |
30,891
-3,570
| -10% | -$347K | 0.16% | 137 |
|
|
2025
Q3 | $3.28M | Sell |
34,461
-3,724
| -10% | -$342K | 0.18% | 125 |
|
|
2025
Q2 | $3.33M | Buy |
38,185
+3,305
| +9% | +$280K | 0.19% | 124 |
|
|
2025
Q1 | $3.13M | Buy |
34,880
+2,237
| +7% | +$200K | 0.2% | 121 |
|
|
2024
Q4 | $2.61M | Buy |
32,643
+7,567
| +30% | +$655K | 0.17% | 128 |
|
|
2024
Q3 | $2.26M | Buy |
25,076
+4,619
| +23% | +$389K | 0.14% | 140 |
|
|
2024
Q2 | $1.61M | Buy |
20,457
+2,933
| +17% | +$240K | 0.11% | 166 |
|
|
2024
Q1 | $1.53M | Buy |
17,524
+1,555
| +10% | +$133K | 0.11% | 175 |
|
|
2023
Q4 | $1.32M | Buy |
15,969
+7,259
| +83% | +$553K | 0.1% | 176 |
|
|
2023
Q3 | $683K | Buy |
8,710
+343
| +4% | +$28.7K | 0.06% | 233 |
|
|
2023
Q2 | $737K | Sell |
8,367
-431
| -5% | -$37.1K | 0.06% | 246 |
|
|
2023
Q1 | $709K | Buy |
8,798
+533
| +6% | +$43.4K | 0.06% | 256 |
|
|
2022
Q4 | $642K | Sell |
8,265
-2,020
| -20% | -$164K | 0.05% | 249 |
|
|
2022
Q3 | $831K | Sell |
10,285
-343
| -3% | -$30.8K | 0.08% | 207 |
|
|
2022
Q2 | $954K | Sell |
10,628
-597
| -5% | -$60.5K | 0.08% | 203 |
|
|
2022
Q1 | $1.25M | Sell |
11,225
-544
| -5% | -$57.5K | 0.1% | 179 |
|
|
2021
Q4 | $1.22M | Sell |
11,769
-388
| -3% | -$44.9K | 0.09% | 174 |
|
|
2021
Q3 | $1.52M | Sell |
12,157
-405
| -3% | -$52.4K | 0.13% | 150 |
|
|
2021
Q2 | $1.56M | Sell |
12,562
-540
| -4% | -$67.8K | 0.13% | 149 |
|
|
2021
Q1 | $1.55M | Sell |
13,102
-207
| -2% | -$24.3K | 0.13% | 145 |
|
|
2020
Q4 | $1.56M | Sell |
13,309
-955
| -7% | -$105K | 0.15% | 134 |
|
|
2020
Q3 | $1.48M | Sell |
14,264
-1,533
| -10% | -$154K | 0.17% | 122 |
|
|
2020
Q2 | $1.45M | Sell |
15,797
-305
| -2% | -$29.2K | 0.18% | 123 |
|
|
2020
Q1 | $1.45M | Sell |
16,102
-110
| -0.7% | -$11.7K | 0.22% | 113 |
|
|
2019
Q4 | $1.84M | Buy |
16,212
+2,113
| +15% | +$232K | 0.23% | 110 |
|
|
2019
Q3 | $1.53M | Buy |
14,099
+2,324
| +20% | +$242K | 0.21% | 116 |
|
|
2019
Q2 | $1.15M | Buy |
11,775
+6,301
| +115% | +$575K | 0.16% | 125 |
|
|
2019
Q1 | $499K | Buy |
+5,474
| New | +$490K | 0.07% | 174 |
|
|
2018
Q4 | – | Sell |
-2,400
| Closed | -$236K | – | 239 |
|
|
2018
Q3 | $236K | Sell |
2,400
-53
| -2% | -$4.9K | 0.04% | 222 |
|
|
2018
Q2 | $210K | Buy |
+2,453
| New | +$205K | 0.03% | 231 |
|
|
2015
Q2 | – | Sell |
-2,802
| Closed | -$219K | – | 182 |
|
|
2015
Q1 | $219K | Sell |
2,802
-2,421
| -46% | -$183K | 0.05% | 169 |
|
|
2014
Q4 | $377K | Buy |
5,223
+34
| +0.7% | +$2.36K | 0.09% | 136 |
|
|
2014
Q3 | $321K | Sell |
5,189
-2,158
| -29% | -$137K | 0.07% | 138 |
|
|
2014
Q2 | $468K | Sell |
7,347
-2,766
| -27% | -$168K | 0.11% | 128 |
|
|
2014
Q1 | $622K | Sell |
10,113
-1,883
| -16% | -$110K | 0.15% | 110 |
|
|
2013
Q4 | $688K | Sell |
11,996
-416
| -3% | -$23.6K | 0.17% | 104 |
|
|
2013
Q3 | $661K | Sell |
12,412
-775
| -6% | -$41.7K | 0.18% | 99 |
|
|
2013
Q2 | $679K | Buy |
+13,187
| New | +$652K | 0.19% | 96 |
|
Other funds holding MDT
VCM
VPM
Foster & Motley's MDT Position: Q1 2026 in Review
Foster & Motley reduced its Medtronic (MDT) stake by 11% in Q1 2026, selling an estimated $332K and leaving 27,428 shares worth $2.38M. The position accounts for 0.12% of the portfolio, ranked #155.
Foster & Motley first reported a position in MDT in Q2 2013 and has held it in 39 quarters since. The position peaked at $3.33M in Q2 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Foster & Motley held 27,428 shares of Medtronic worth $2.38M as of Q1 2026.
- Foster & Motley sold 3,463 Medtronic shares in Q1 2026, an estimated $332K.
- Medtronic made up 0.12% of Foster & Motley's portfolio in Q1 2026, its #155 holding.
- Foster & Motley first reported a position in Medtronic in Q2 2013 and has held it in 39 quarters since.
- Foster & Motley's Medtronic position peaked at $3.33M in Q2 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Foster & Motley's 13F filing for Q1 2026, filed 21 Apr 2026.